These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38620391)

  • 1. Emerging patterns of hypercoagulability associated with critical COVID-19: A review.
    Frazer JS; Tyrynis Everden AJ
    Trends Anaesth Crit Care; 2020 Oct; 34():4-13. PubMed ID: 38620391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 versus HIT hypercoagulability.
    Warkentin TE; Kaatz S
    Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 coagulopathy - what should we treat?
    Chowdary P
    Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Proportion of Patients With Musculoskeletal Tumors Demonstrate Thromboelastographic Markers of Hypercoagulability? A Pilot Study.
    Sabharwal S; Jalloh HB; Levin AS; Morris CD
    Clin Orthop Relat Res; 2023 Mar; 481(3):553-561. PubMed ID: 35901446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.
    Manolis AS; Manolis TA; Manolis AA; Papatheou D; Melita H
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):12-24. PubMed ID: 32924567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1397-1413. PubMed ID: 33832398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019.
    Wada H; Shiraki K; Shimpo H; Shimaoka M; Iba T; Suzuki-Inoue K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 related thrombosis: A mini-review.
    Cheng NM; Chan YC; Cheng SW
    Phlebology; 2022 Jun; 37(5):326-337. PubMed ID: 35403487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To Study the Correlation of Clinical Severity and Cytokine Storm in COVID-19 Pulmonary Embolism Patients by Using Computed Tomography Pulmonary Angiography (CTPA) Qanadli Clot Burden Scoring System.
    Ali L; Sharif M; Naqvi SGA; Mohammed I; Baig MA; Sidratul Muntaha K; Chalil AR; Ali H; Aweida HA; Iqrar A
    Cureus; 2023 May; 15(5):e39263. PubMed ID: 37342749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Infusion Low-Dose Unfractionated Heparin for the Management of Hypercoagulability Associated With COVID-19.
    Li M; Gitarts S; Nyabera A; Kondaveeti R; Hammudeh Y; Gonzalez C; Trandafirescu T; Penumadu A; Lopez R; Sahibzada A; La Cruz A; Rahman H
    J Pharm Pract; 2022 Apr; 35(2):205-211. PubMed ID: 35484870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
    Viecca M; Radovanovic D; Forleo GB; Santus P
    Pharmacol Res; 2020 Aug; 158():104950. PubMed ID: 32450344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability.
    Zarrouk S; Finsterer J
    Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):132. PubMed ID: 34602810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene.
    Warkentin TE
    J Thromb Haemost; 2018 Nov; 16(11):2128-2132. PubMed ID: 30099843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation.
    Chandel A; Patolia S; Looby M; Bade N; Khangoora V; King CS
    J Intensive Care Med; 2021 Jun; 36(6):689-695. PubMed ID: 33641491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of COVID-19 on the Organs.
    Jain U
    Cureus; 2020 Aug; 12(8):e9540. PubMed ID: 32905500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
    Panigada M; Bottino N; Tagliabue P; Grasselli G; Novembrino C; Chantarangkul V; Pesenti A; Peyvandi F; Tripodi A
    J Thromb Haemost; 2020 Jul; 18(7):1738-1742. PubMed ID: 32302438
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.